These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 107311)

  • 21. New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
    Van Schepdael A; Busson R; Vanderhaeghe HJ; Claes PJ; Verbist L; Mingeot-Leclercq MP; Brasseur R; Tulkens PM
    J Med Chem; 1991 Apr; 34(4):1483-92. PubMed ID: 2016726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1995 Jun; 35(6):865-8. PubMed ID: 7559197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
    Herzog IM; Louzoun Zada S; Fridman M
    J Med Chem; 2016 Sep; 59(17):8008-18. PubMed ID: 27509271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syntheses and properties of kanamycin C derivatives active against resistant bacteria.
    Kondo S; Miyasaka T; Yoshida K; Iinuma K; Umezawa H
    J Antibiot (Tokyo); 1977 Dec; 30(12):1150-2. PubMed ID: 340436
    [No Abstract]   [Full Text] [Related]  

  • 25. Aminoglycoside antibiotics. XII. Effect of N-alkylation in kanamycin antibiotics.
    Nakagawa S; Toda S; Abe Y; Yamashita H; Fujisawa KI; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1978 Jul; 31(7):675-80. PubMed ID: 690002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semisynthetic aminoglycoside antibacterials. 6. Synthesis of sisomicin, Antibiotic G-52, and novel 6'-substituted analogues of sisomicin from aminoglycoside 66-40C.
    Davies DH; Mallams AK; Counelis M; Loebenberg D; Moss EL; Waitz JA
    J Med Chem; 1978 Feb; 21(2):189-93. PubMed ID: 413921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-resistance between some aminoglycoside antibiotics.
    Onaolapo JA
    Afr J Med Med Sci; 1994 Sep; 23(3):215-9. PubMed ID: 7604744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance of Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Holmes RK; Minshew BH; Sanford JP
    J Infect Dis; 1974 Nov; 130 Suppl(0):S163-5. PubMed ID: 4214382
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antibacterial activity of 6'-N-alkyl derivatives of 1-N-[(S)-4-amino-2-hydroxybutyryl]-kanamycin.
    Umezawa H; Iinuma K; Kondo S; Maeda K
    J Antibiot (Tokyo); 1975 Jun; 28(6):483-5. PubMed ID: 807548
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals].
    Witchitz JL; Golstein FW; Pangon B; Christol D; Acar JF
    Nouv Presse Med; 1979 Oct; 8(42):3417-20. PubMed ID: 537886
    [No Abstract]   [Full Text] [Related]  

  • 34. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa.
    Ximenes J; Bassoi ON; de Menezes JP; Fry W
    J Int Med Res; 1976; 4(3):165-75. PubMed ID: 829072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition.
    Linzenmeier G; Naumann P; Neussel H; Rosin H
    J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
    Van Schepdael A; Delcourt J; Mulier M; Busson R; Verbist L; Vanderhaeghe HJ; Mingeot-Leclercq MP; Tulkens PM; Claes PJ
    J Med Chem; 1991 Apr; 34(4):1468-75. PubMed ID: 2016724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefoxitin: synergism with aminoglycosides in vitro.
    Une T; Osada Y; Ogawa H
    Arzneimittelforschung; 1981; 31(5):761-4. PubMed ID: 6791664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibacterial effects of the combinations of azlocillin with other antibiotics].
    Courtieu AL; Billaudel S; Reynaud A; Drugeon HB
    Presse Med; 1984 Mar; 13(13):785-7. PubMed ID: 6231595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activity of temocillin in combination with other beta-lactam antibiotics.
    Verbist L; Verhaegen J
    Drugs; 1985; 29 Suppl 5():32-7. PubMed ID: 3928322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents.
    Bera S; Zhanel GG; Schweizer F
    Bioorg Med Chem Lett; 2010 May; 20(10):3031-5. PubMed ID: 20413307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.